Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-08

Clinical Trial Update: Brain Response to Single Dose of Pregabalin in Fibromyalgia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update evaluating brain response to a single dose of pregabalin in fibromyalgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Fibromyalgia | Phase 2, Phase 3 | Status: COMPLETED